
DOI . ORG {
}
Title[redir]:
Rapamycin induces Smad activity in prostate cancer cell lines | Urolithiasis
Description:
Rapamycin inhibits the FK506-binding protein 12 (FKBP12)/mammalian target of rapamycin (mTOR) complex and causes cell cycle arrest in G1. The precise mechanism of growth inhibition by rapamycin is only partly understood. Rapamycin led to growth inhibition in the human prostate cancer cell lines LNCaP and PC3 cells after 72 h, ID50: 93 and 50 nM, respectively. Filter cDNA array analysis showed down-regulation by more than 0.75× by rapamycin in PC3 cells and LNCaP cells of the following genes: follistatin, eukaryotic initiation factor-4E (eIF4E), glucose-6-phosphate dehydrogenase (GAPDH), lactate dehydrogenase (LDH)-A, ATP synthase, heat shock protein (HSP)-1. Upregulation by more than 1.5× was found for: bone morphogenetic protein (BMP)-4, FKBP12, carcinoma embryonic antigen (CEA) precursor, eukaryotic initiation factor (eIF)-3 p36 subunit, latent transforming growth factor (TGF) beta binding protein (LTBP)1. Rapamycin induced BMP4 and reduced follistatin expression in PC3 cells. This resulted in a dose-dependent nuclear expression of Smad4 and activated the SBE4 Smad-reporter, indicating activation of TGFbeta/BMP signaling. Combining rapamycin with PI3K inhibition (LY294002) increased growth inhibition. These findings illustrate that Smad signaling plays a role in the anticancer effects of rapamycin and show that combination with PI3K inhibition improves growth inhibition.
Matching Content Categories {📚}
- Science
- Social Networks
- Education
Content Management System {📝}
What CMS is doi.org built with?
Custom-built
No common CMS systems were detected on Doi.org, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of doi.org audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Doi.org Make Money? {💸}
We find it hard to spot revenue streams.
Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Doi.org has a revenue plan, but it's either invisible or we haven't found it.
Keywords {🔍}
article, rapamycin, cancer, growth, inhibition, privacy, cookies, content, research, smad, prostate, cell, protein, access, information, publish, search, van, cells, factor, analysis, data, log, journal, lines, poel, hanrahan, zhong, follistatin, discover, signalling, department, oncology, usa, springer, optional, personal, parties, policy, find, track, urological, induces, activity, cite, simons, explore, target, mtor, mechanism,
Topics {✒️}
month download article/chapter eukaryotic initiation factor-4e bone morphogenetic protein winship cancer institute dose-dependent nuclear expression rapamycin induced bmp4 eukaryotic initiation factor increased growth inhibition full article pdf van der poel reduced follistatin expression privacy choices/manage cookies sbe4 smad-reporter smad signaling plays cell cycle arrest fk506-binding protein 12 heat shock protein beta binding protein related subjects growth inhibition european economic area scope submit manuscript carcinoma embryonic antigen inhibiting smad3 phosphorylation tak1 promotes emt conditions privacy policy glucose-6-phosphate dehydrogenase accepting optional cookies tgfbeta/bmp signaling article log main content log journal finder publish usage analysis article cite pi3k inhibition information check access instant access lncap cells tgf privacy policy personal data books a rapamycin inhibits rapamycin led combining rapamycin optional cookies manage preferences follistatin data protection
Schema {🗺️}
WebPage:
mainEntity:
headline:Rapamycin induces Smad activity in prostate cancer cell lines
description: Rapamycin inhibits the FK506-binding protein 12 (FKBP12)/mammalian target of rapamycin (mTOR) complex and causes cell cycle arrest in G1. The precise mechanism of growth inhibition by rapamycin is only partly understood. Rapamycin led to growth inhibition in the human prostate cancer cell lines LNCaP and PC3 cells after 72 h, ID50: 93 and 50 nM, respectively. Filter cDNA array analysis showed down-regulation by more than 0.75× by rapamycin in PC3 cells and LNCaP cells of the following genes: follistatin, eukaryotic initiation factor-4E (eIF4E), glucose-6-phosphate dehydrogenase (GAPDH), lactate dehydrogenase (LDH)-A, ATP synthase, heat shock protein (HSP)-1. Upregulation by more than 1.5× was found for: bone morphogenetic protein (BMP)-4, FKBP12, carcinoma embryonic antigen (CEA) precursor, eukaryotic initiation factor (eIF)-3 p36 subunit, latent transforming growth factor (TGF) beta binding protein (LTBP)1. Rapamycin induced BMP4 and reduced follistatin expression in PC3 cells. This resulted in a dose-dependent nuclear expression of Smad4 and activated the SBE4 Smad-reporter, indicating activation of TGFbeta/BMP signaling. Combining rapamycin with PI3K inhibition (LY294002) increased growth inhibition. These findings illustrate that Smad signaling plays a role in the anticancer effects of rapamycin and show that combination with PI3K inhibition improves growth inhibition.
datePublished:
dateModified:
pageStart:380
pageEnd:386
sameAs:https://doi.org/10.1007/s00240-002-0282-1
keywords:
Bone morphogenetic protein Follistatin Rapamycin Prostate cancer Transforming growth factor (TGF) Mammalian target of rapamycin (mTOR)
Urology
Nephrology
Medical Biochemistry
image:
isPartOf:
name:Urological Research
issn:
1434-0879
0300-5623
volumeNumber:30
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name: H. van der Poel
affiliation:
name:Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute, Department of Urology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
address:
name:Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute, Department of Urology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands,
type:PostalAddress
type:Organization
type:Person
name: C. Hanrahan
affiliation:
name:Department of Oncology, Johns Hopkins Oncology Center, Baltimore, MD, USA
address:
name:Department of Oncology, Johns Hopkins Oncology Center, Baltimore, MD, USA,
type:PostalAddress
type:Organization
type:Person
name: H. Zhong
affiliation:
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA
address:
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA,
type:PostalAddress
type:Organization
type:Person
name: J. Simons
affiliation:
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA
address:
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA,
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Rapamycin induces Smad activity in prostate cancer cell lines
description: Rapamycin inhibits the FK506-binding protein 12 (FKBP12)/mammalian target of rapamycin (mTOR) complex and causes cell cycle arrest in G1. The precise mechanism of growth inhibition by rapamycin is only partly understood. Rapamycin led to growth inhibition in the human prostate cancer cell lines LNCaP and PC3 cells after 72 h, ID50: 93 and 50 nM, respectively. Filter cDNA array analysis showed down-regulation by more than 0.75× by rapamycin in PC3 cells and LNCaP cells of the following genes: follistatin, eukaryotic initiation factor-4E (eIF4E), glucose-6-phosphate dehydrogenase (GAPDH), lactate dehydrogenase (LDH)-A, ATP synthase, heat shock protein (HSP)-1. Upregulation by more than 1.5× was found for: bone morphogenetic protein (BMP)-4, FKBP12, carcinoma embryonic antigen (CEA) precursor, eukaryotic initiation factor (eIF)-3 p36 subunit, latent transforming growth factor (TGF) beta binding protein (LTBP)1. Rapamycin induced BMP4 and reduced follistatin expression in PC3 cells. This resulted in a dose-dependent nuclear expression of Smad4 and activated the SBE4 Smad-reporter, indicating activation of TGFbeta/BMP signaling. Combining rapamycin with PI3K inhibition (LY294002) increased growth inhibition. These findings illustrate that Smad signaling plays a role in the anticancer effects of rapamycin and show that combination with PI3K inhibition improves growth inhibition.
datePublished:
dateModified:
pageStart:380
pageEnd:386
sameAs:https://doi.org/10.1007/s00240-002-0282-1
keywords:
Bone morphogenetic protein Follistatin Rapamycin Prostate cancer Transforming growth factor (TGF) Mammalian target of rapamycin (mTOR)
Urology
Nephrology
Medical Biochemistry
image:
isPartOf:
name:Urological Research
issn:
1434-0879
0300-5623
volumeNumber:30
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name: H. van der Poel
affiliation:
name:Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute, Department of Urology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
address:
name:Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute, Department of Urology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands,
type:PostalAddress
type:Organization
type:Person
name: C. Hanrahan
affiliation:
name:Department of Oncology, Johns Hopkins Oncology Center, Baltimore, MD, USA
address:
name:Department of Oncology, Johns Hopkins Oncology Center, Baltimore, MD, USA,
type:PostalAddress
type:Organization
type:Person
name: H. Zhong
affiliation:
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA
address:
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA,
type:PostalAddress
type:Organization
type:Person
name: J. Simons
affiliation:
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA
address:
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA,
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Urological Research
issn:
1434-0879
0300-5623
volumeNumber:30
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute, Department of Urology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
address:
name:Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute, Department of Urology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands,
type:PostalAddress
name:Department of Oncology, Johns Hopkins Oncology Center, Baltimore, MD, USA
address:
name:Department of Oncology, Johns Hopkins Oncology Center, Baltimore, MD, USA,
type:PostalAddress
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA
address:
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA,
type:PostalAddress
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA
address:
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA,
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name: H. van der Poel
affiliation:
name:Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute, Department of Urology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
address:
name:Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute, Department of Urology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands,
type:PostalAddress
type:Organization
name: C. Hanrahan
affiliation:
name:Department of Oncology, Johns Hopkins Oncology Center, Baltimore, MD, USA
address:
name:Department of Oncology, Johns Hopkins Oncology Center, Baltimore, MD, USA,
type:PostalAddress
type:Organization
name: H. Zhong
affiliation:
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA
address:
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA,
type:PostalAddress
type:Organization
name: J. Simons
affiliation:
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA
address:
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA,
type:PostalAddress
type:Organization
PostalAddress:
name:Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute, Department of Urology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands,
name:Department of Oncology, Johns Hopkins Oncology Center, Baltimore, MD, USA,
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA,
name:Department of Oncology, Winship Cancer Institute, Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA,
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(72)
- How much does https://link.springer.com/privacystatement gross monthly?
- How much profit does https://link.springer.com/article/10.1007/s00240-002-0282-1/#main make?
- How much does https://link.springer.com generate monthly?
- Financial intake of https://idp.springer.com/auth/personal/springernature?redirect_uri=https://link.springer.com/article/10.1007/s00240-002-0282-1
- What's the income of https://link.springer.com/article/10.1007/s00240-002-0282-1/#eds-c-header-nav?
- How much income is https://link.springer.com/journals/ earning monthly?
- How much does https://www.springernature.com/gp/authors make?
- How much does https://link.springernature.com/home/ earn?
- What's the profit of https://link.springer.com/article/10.1007/s00240-002-0282-1/#eds-c-header-popup-search?
- What's the financial outcome of https://order.springer.com/public/cart?
- How much income is https://link.springer.com/article/10.1007/s00240-002-0282-1/ earning monthly?
- What's the income of https://link.springer.com/article/10.1007/s00240-002-0282-1/journal/240?
- What's the financial outcome of https://link.springer.com/article/10.1007/s00240-002-0282-1/#citeas?
- Earnings of https://link.springer.com/article/10.1007/s00240-002-0282-1/journal/240/aims-and-scope
- What's https://submission.nature.com/new-submission/240/3's gross income?
- How much does https://link.springer.com/article/10.1007/s00240-002-0282-1/#auth-_H_-van_der_Poel-A1 bring in each month?
- What are the total earnings of https://link.springer.com/article/10.1007/s00240-002-0282-1/#A1?
- What is the earnings of https://link.springer.com/article/10.1007/s00240-002-0282-1/#auth-_C_-Hanrahan-A2?
- What's the financial gain of https://link.springer.com/article/10.1007/s00240-002-0282-1/#A2?
- See how much https://link.springer.com/article/10.1007/s00240-002-0282-1/#auth-_H_-Zhong-A3 makes per month
- How much does https://link.springer.com/article/10.1007/s00240-002-0282-1/#A3 gross monthly?
- How much does https://link.springer.com/article/10.1007/s00240-002-0282-1/#auth-_J_-Simons-A3 generate monthly?
- How much does https://link.springer.com/article/10.1007/s00240-002-0282-1/article/10.1007/s00240-002-0282-1/metrics net monthly?
- How much does https://wayf.springernature.com?redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00240-002-0282-1 generate monthly?
- Get to know what's the income of https://link.springer.com/product/springer-plus
- Discover the revenue of https://www.springernature.com/gp/librarians/licensing/agc/journals
- Earnings of https://link.springer.com/10.1038/s41420-021-00657-z?fromPaywallRec=true
- https://link.springer.com/10.1007/s11356-021-16542-2?fromPaywallRec=true income
- How much revenue does https://link.springer.com/10.1038/s41388-018-0655-8?fromPaywallRec=true generate?
- What's the monthly money flow for https://link.springer.com/article/10.1007/s00240-002-0282-1/subjects/cancer-therapeutic-resistance?
- What's the income of https://link.springer.com/article/10.1007/s00240-002-0282-1/subjects/growth-factor-signalling?
- How much revenue does https://link.springer.com/article/10.1007/s00240-002-0282-1/subjects/insulin-signalling generate?
- Get to know what's the income of https://link.springer.com/article/10.1007/s00240-002-0282-1/subjects/prostate-cancer
- How much income is https://link.springer.com/article/10.1007/s00240-002-0282-1/subjects/tor-signalling earning monthly?
- Discover the revenue of https://link.springer.com/article/10.1007/s00240-002-0282-1/subjects/tumour-suppressor-proteins
- What's the income generated by https://link.springer.com/article/10.1007/s00240-002-0282-1/search?sortBy=newestFirst&dc.creator=%20H.%20van%20der%20Poel each month?
- How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=%20H.%20van%20der%20Poel have monthly?
- How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22%20H.%20van%20der%20Poel%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much profit does https://link.springer.com/article/10.1007/s00240-002-0282-1/search?sortBy=newestFirst&dc.creator=%20C.%20Hanrahan make?
- Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=%20C.%20Hanrahan
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22%20C.%20Hanrahan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://link.springer.com/article/10.1007/s00240-002-0282-1/search?sortBy=newestFirst&dc.creator=%20H.%20Zhong pull in?
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=%20H.%20Zhong make?
- See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22%20H.%20Zhong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
- What's the financial intake of https://link.springer.com/article/10.1007/s00240-002-0282-1/search?sortBy=newestFirst&dc.creator=%20J.%20Simons?
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=%20J.%20Simons?
- Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22%20J.%20Simons%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What is the earnings of https://s100.copyright.com/AppDispatchServlet?title=Rapamycin%20induces%20Smad%20activity%20in%20prostate%20cancer%20cell%20lines&author=%20H.%20van%20der%20Poel%20et%20al&contentID=10.1007%2Fs00240-002-0282-1©right=Springer-Verlag&publication=0300-5623&publicationDate=2003-02&publisherName=SpringerNature&orderBeanReset=true?
- How much does https://citation-needed.springer.com/v2/references/10.1007/s00240-002-0282-1?format=refman&flavour=citation pull in?
- Explore the financials of https://link.springer.com/article/10.1007/s00240-002-0282-1/search?query=Bone%20morphogenetic%20protein%20Follistatin%20Rapamycin%20Prostate%20cancer%20Transforming%20growth%20factor%20%28TGF%29%20Mammalian%20target%20of%20rapamycin%20%28mTOR%29&facet-discipline="Medicine%20%26%20Public%20Health"
- What's the financial intake of https://link.springer.com/journals/a/1?
- How much does https://link.springer.com/books/a/1 make?
- Explore the financials of https://link.springer.com/journals
- How much profit is https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral making per month?
- Earnings of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
- What's https://www.springernature.com/gp/products's gross income?
- How much profit is https://www.springernature.com/gp/librarians making per month?
- Get to know what's the income of https://www.springernature.com/gp/societies
- Discover the revenue of https://www.springernature.com/gp/partners
- How much money does https://www.springer.com/ make?
- Revenue of https://www.nature.com/
- How much does https://www.biomedcentral.com/ generate monthly?
- What's https://www.palgrave.com/'s gross income?
- How much revenue does https://www.apress.com/ generate?
- How profitable is https://link.springer.com/brands/discover?
- How much money does https://www.springernature.com/gp/legal/ccpa generate?
- What's the profit of https://www.springernature.com/gp/info/accessibility?
- What's the monthly income of https://link.springer.com/termsandconditions?
- What are the total earnings of https://support.springernature.com/en/support/home?
- How much revenue does https://link.springer.com/legal-notice produce monthly?
- How much income does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations have?
- What is the earnings of https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
Emails and Hosting {✉️}
Mail Servers:
- mx.zoho.eu
- mx2.zoho.eu
- mx3.zoho.eu
Name Servers:
- josh.ns.cloudflare.com
- zita.ns.cloudflare.com
CDN Services {📦}
- Crossref